[个性化,适应计算机认知刺激计划对刺激轻度或主观认知障碍的年轻人和老年人的休活动的影响. 随机对照试验的协议]随机对照试验的协议]
Isabel Gómez-Soria1, Bárbara Oliván-Blázquez2, Alejandra Aguilar-Latorre3
1University of Zaragoza. Faculty of Health Sciences. Department of Physiatry and Nursing. Zaragoza. isabelgs@unizar.es.
Anales del sistema sanitario de Navarra
|May 6, 2025
概括
这项研究将计算机认知刺激与轻度认知障碍的休活动进行了比较. 这两项干预都显示了对老年人认知功能的潜在益处.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 认知心理学 认知心理学
背景情况:
- 轻度认知障碍 (MCI) 是正常衰老和痴呆症之间的关键阶段.
- 主观认知障碍 (SCI) 预测到痴呆的进展.
- 认知刺激可以缓解认知衰退.
研究的目的:
- 为了比较个性化计算机认知刺激 (PCCS) 与刺激休活动.
- 评估患有MCI或SCI的年轻人和老年人的干预措施.
- 评估认知干预对全球认知,记忆和情绪的有效性.
主要方法:
- 随机对照试验与59个社区居住的西班牙成年人 (年龄=50).
- 干预措施:PCCS (30分钟/天,5天/周) 或休活动 (2-5活动/周) 8周.
- 对照组接受了通常的护理. 主要结果:全球认知;次要:记忆力,语言流性,ADL,情绪.
主要成果:
- 数据尚未提供,因为研究仍在进行中.
- 结果将在8周的干预期后进行分析.
- 主要和次要结果将在各组之间进行比较.
结论:
- 该研究将确定PCCS与休活动的比较有效性.
- 这些发现将为患有痴呆症风险的个人提供干预信息.
- 这项研究有助于了解认知储备和老化中的大脑健康.
更多相关视频
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.5K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.2K
相关概念视频
01:30Cognitive Development During Adulthood
28
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
28
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85